Medical Oncologist
Side effects — Osimertinib
Breathlessness or New Cough on Osimertinib — Recognising Lung Injury
A new cough or worsening breathlessness on osimertinib is not something to sleep off. It can be the first sign of interstitial lung disease — a serious inflammation of the lung tissue that needs same-day assessment from your oncology team.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Not a chest infection — ILD is a drug-related lung reaction, not an infection. Antibiotics do not treat it, and assuming it will settle can be dangerous.
- It can worsen quickly — Symptoms that feel mild today can become severe over days. Same-day contact is the safe default.
- Treatable when found early — Caught promptly, most cases of ILD are manageable. Delay is what makes it dangerous.
- Any new cough counts — Even a mild dry cough that started after osimertinib began is worth reporting to your team today.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
A new cough or worsening breathlessness on osimertinib must not be dismissed as a chest infection or anxiety. It can be interstitial lung disease, a serious inflammation of the lung tissue that NCCN and ESMO classify as needing urgent assessment. Call your oncology team today — do not wait for your next appointment.
Is there anything you can safely manage at home?
No. Interstitial lung disease is not something you can manage with rest, steam inhalation, or over-the-counter medicines. There is no safe home treatment for this, and waiting to see if it improves is not a safe approach with this symptom on this drug.
Do not take an extra puff of an inhaler and assume the problem is solved. Inhalers treat airway narrowing, not inflammation of the lung tissue itself.
If you have a new cough or breathlessness that started after you began osimertinib, the right action is to contact your oncology team today — not after the weekend, not at your next scheduled visit.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Not sure whether this counts as an emergency?
Call the helpline. It is always better to check than to wait.
How serious is your breathlessness right now?
| What you notice | How urgent | Action |
|---|---|---|
| New dry cough that was not there before osimertinib | Mild — still needs review | Call your oncology team today |
| Breathlessness walking up stairs or across a room | Moderate — do not wait | Call your oncology team today; expect to be seen the same day |
| Breathlessness getting dressed or moving around the house | Severe — urgent | Go to hospital now; do not wait for a callback |
| Breathlessness sitting still or lying down | Very severe — emergency | Go to the emergency department immediately |
| Fever alongside any of the above | Emergency regardless of other severity | Go to the emergency department now |
| Typically starts | Weeks to months after starting osimertinib; most often in the early months of treatment — but can occur at any point | Report any new lung symptom at any stage of treatment |
What else should you know about ILD and osimertinib?
Will ILD mean stopping osimertinib permanently?
Not necessarily. The decision depends on how severe the reaction is and how quickly it responds to treatment. Mild cases may allow treatment to be restarted once the inflammation settles, usually after the drug is held and your lungs are reassessed. More severe reactions may require a permanent change of treatment. Your oncologist will not make that decision until your response to initial management is clear. Reporting early is what keeps the milder options available.
What tests will my team do if they suspect ILD?
The first step is usually a chest X-ray or CT scan of the lungs to look for changes in the lung tissue consistent with ILD. Blood tests are done to check for infection and assess your overall condition. A pulse oximetry reading will be taken to measure your oxygen levels. The pattern of changes on the scan, combined with your symptoms and the timing since you started osimertinib, is what guides the diagnosis. Your team may involve a pulmonologist — a lung specialist — to help interpret the findings.
How do I know it is not just a chest infection?
You probably cannot tell on your own, and that is exactly why the symptom needs professional assessment. A chest infection and ILD can feel similar — new cough, breathlessness, sometimes fever. The difference matters enormously because the treatments are different: ILD is not treated with antibiotics and may require steroids, while an infection is treated the other way around. Your team will use scan results and blood tests to tell them apart. Do not assume it is an infection and treat yourself with leftover antibiotics.
What does treatment for ILD involve?
The first step is almost always to hold osimertinib while the lung inflammation is assessed and managed. Mild inflammation may settle with close monitoring and rest. More significant inflammation is typically treated with corticosteroids, which dampen the immune reaction in the lung tissue. The steroid course is usually tapered slowly rather than stopped abruptly. Oxygen support may be needed if your levels are affected. Your team will monitor recovery with repeat scans before deciding on the next step for your cancer treatment.
Can ILD happen even if I feel generally well?
Yes. In some cases the lungs show changes on a scan before symptoms become obvious. This is one reason why your oncology team will monitor you with imaging at intervals during treatment. However, most people do notice something — a new cough or reduced exercise tolerance — before the changes become severe. Trusting that change and reporting it, rather than attributing it to fitness or the weather, is the most important thing you can do. If something has shifted in your breathing since starting osimertinib, that observation is worth telling your team.
Explore 75 more Lung Cancer Targeted Medicines topics
Drug Deep Dive: Osimertinib (Tagrisso)
- Adjuvant Osimertinib After Lung Cancer Surgery: Three Years of Tablets
- Breathlessness or New Cough on Osimertinib: Recognising Lung Injury (ILD)
- Diet and Nutrition While on Osimertinib
- Drug, Food and Supplement Interactions With Osimertinib
- Fertility, Pregnancy and Contraception on Osimertinib
- Heart Rhythm and Ejection Fraction Changes on Osimertinib
- How Does Osimertinib Work? The Third-Generation EGFR Inhibitor Explained
- How Long Does Osimertinib Take to Work?
- How Long Will You Stay on Osimertinib?
- Osimertinib (Tagrisso): The Complete Patient Guide
- Osimertinib Myths: Clear Scans, Stopping Early and Generic Quality
- Osimertinib Price in India: Brand, Generic and Monthly Cost
- Osimertinib Side Effects: The Complete List and Timeline
- Osimertinib Success Rate and Survival: An Honest Look at the Numbers
- Osimertinib With Chemotherapy: Who Actually Benefits From the Combination?
- Osimertinib and Brain Metastases: Why It Works Inside the Brain
- Osimertinib in Elderly Patients and Those With Other Illnesses
- Osimertinib vs Gefitinib and Erlotinib: Is the Costlier Drug Worth It?
- Rash, Dry Skin and Nail Problems on Osimertinib
- Taking Osimertinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Osimertinib
- When Osimertinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Osimertinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Osimertinib?
- Work, Travel and Daily Life on Osimertinib
Drug Deep Dive: Alectinib (Alecensa)
- Alectinib (Alecensa, Alectinib): The Complete Patient Guide
- Alectinib After Surgery for Early-Stage ALK-Positive Lung Cancer
- Alectinib Myths: Is ALK-Positive Cancer 'Curable'?
- Alectinib Price in India: Brand, Generic and Monthly Cost
- Alectinib Side Effects: The Complete List and Timeline
- Alectinib Success Rate and Survival: An Honest Look at the Numbers
- Alectinib and Brain Metastases: How It Protects the Brain
- Alectinib in Elderly Patients and Those With Other Illnesses
- Alectinib vs Crizotinib vs Lorlatinib: Choosing an ALK Inhibitor
- Diet and Nutrition While on Alectinib
- Do You Need Chemotherapy Alongside Alectinib?
- Drug, Food and Supplement Interactions With Alectinib
- Fertility, Pregnancy and Contraception on Alectinib
- How Does Alectinib Work? The Second-Generation ALK Inhibitor Explained
- How Long Does Alectinib Take to Work?
- How Long Will You Stay on Alectinib?
- Muscle Pain and High CPK on Alectinib: When to Worry
- Severe Sun Sensitivity on Alectinib: Preventing Serious Burns
- Taking Alectinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Alectinib
- Weight Gain, Constipation and a Slow Pulse on Alectinib
- When Alectinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Alectinib? ALK-Positive Lung Cancer
- Will Insurance or a Government Scheme Pay for Alectinib?
- Work, Travel and Daily Life on Alectinib
Drug Deep Dive: Gefitinib (Iressa)
- Diarrhoea on Gefitinib: Home Management and Warning Signs
- Diet and Nutrition While on Gefitinib
- Fertility, Pregnancy and Contraception on Gefitinib
- Gefitinib (Iressa, Geftinat, Geftib): The Complete Patient Guide
- Gefitinib Myths: 'It's Only for Poor Patients' and Other Half-Truths
- Gefitinib Plus Chemotherapy: Does Adding Chemo Actually Help?
- Gefitinib Price in India: Brand, Generic and Monthly Cost
- Gefitinib Rash: Why It Appears in Week Two and How to Treat It
- Gefitinib Side Effects: The Complete List and Timeline
- Gefitinib Success Rate and Survival: An Honest Look at the Numbers
- Gefitinib and Antacids: The Interaction That Silently Reduces Absorption
- Gefitinib in Early-Stage vs Advanced Lung Cancer: Different Goals
- Gefitinib in Elderly Patients and Those With Other Illnesses
- Gefitinib vs Osimertinib: Making the Decision When Cost Matters
- How Does Gefitinib Work? The First-Generation EGFR Inhibitor Explained
- How Long Does Gefitinib Take to Work?
- How Long Will You Stay on Gefitinib?
- Raised Liver Enzymes on Gefitinib: What Your LFT Report Means
- T790M Testing After Gefitinib Stops Working: The Next Step Explained
- Taking Gefitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Gefitinib
- When Gefitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Gefitinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Gefitinib?
- Work, Travel and Daily Life on Gefitinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
How common is ILD with osimertinib?
ILD occurs in a proportion of patients taking osimertinib, and it is one of the side effects your oncology team monitors for throughout treatment. The risk is real enough that any new respiratory symptom is taken seriously. NCCN and ESMO both include ILD as a monitored adverse event in their guidance for EGFR-targeted therapies. Your team will have discussed this risk with you at the start of treatment; if they did not, ask them directly at your next visit.
Can ILD come on suddenly?
It usually develops over days to weeks rather than minutes to hours, but symptoms can worsen faster than expected once they begin. Starting with a dry cough and progressing to significant breathlessness within a few days is a pattern that has been reported. This is why the safe approach is same-day contact rather than monitoring at home — do not reassure yourself that today's mild symptom means tomorrow will be the same.
Is it safe to continue osimertinib while waiting for test results?
This decision belongs to your oncologist, not to you or your family. Do not stop or continue the medicine on your own judgement. Your team will advise you whether to hold the tablet while investigations are done, and their answer will depend on how significant your symptoms are and what the initial tests show. Call them today rather than making that decision yourself in either direction.
What if I had some breathlessness before osimertinib — how do I know if it has changed?
If you had breathlessness before starting osimertinib, what matters is whether it has clearly worsened since you began the drug. Think about what you could do before starting — could you walk to the end of the road without stopping, or climb one flight of stairs? If your exercise tolerance has clearly decreased, that change is what your team needs to know about, even if you had breathlessness before. A written note of what you could do versus what you notice now is the clearest way to communicate this at your appointment.
Should I go to a general hospital or straight to my oncology centre?
If you have red-flag symptoms — breathlessness at rest, blue lips, chest pain, or fever alongside breathlessness — go to the nearest emergency department, not to a planned appointment. For symptoms that are new but not immediately severe, contact your oncology team first, as they can direct you to the most appropriate setting and alert the team there to your background. Carrying your current medicine list and knowing your osimertinib dose helps any emergency team understand your situation quickly.